Intravascular ultrasonography can precisely measure plaque and is being used to test new drug therapies. Other imaging tests may also prove useful to identify people at risk for coronary artery disease and to monitor treatment.
Genetic discoveries have changed our understanding of the cardiomyopathies but are only beginning to change our clinical practice.